ArticleEpilepsia open2024

Long-term efficacy and safety of cannabidiol in patients with tuberous sclerosis complex: 3-year results from the cannabidiol expanded access program.

Arie Weinstock et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.